hepatitis C drugs | Drug Injury Watch

Health Canada: There Is No Apparent Link Between Sovaldi Or Harvoni With Liver Cancer Recurrence As Of April 2017

June 1, 2017

Drug Regulatory Agency Has Requested Additional Safety Information From Some Manufacturers Of Direct-Acting Antivirals (DAAs) (Posted by Tom Lamb at DrugInjuryWatch.com) The May 2017 edition of Health Product InfoWatch included this report, “Summary…

February 2017 Label Changes For Sovaldi, Harvoni, And Other DAA Hepatitis C Drugs Are Made So As To Add A “Black-Box” Warning

February 16, 2017

Drug Safety Regulators Flag An Increased Risk Of Hepatitis B Virus Reactivation Which Can Result In Cases Of Fulminant Hepatitis, Liver Failure, And Death (Posted by Tom Lamb at DrugInjuryWatch.com) In February…

New Safety Issue: Direct-Acting Antivirals Drugs For Hepatitis C Such As Harvoni And Sovaldi Could Cause Liver Failure

January 27, 2017

January 2017 ISMP Report: FDA Database Has 524 Cases Of Liver Failure, Including 165 Deaths, And 1,058 Reports Of Severe Liver Injury (Posted by Tom Lamb at DrugInjuryWatch.com) A January 24, 2017…

Is Liver Cancer Associated With Harvoni, Sovaldi, And Other Direct-Acting Antiviral Medications For Hepatitis C?

January 11, 2017

Conflicting Findings From Different Medical Studies Leave The Extent Of This Drug Safety Issue Uncertain At Present Time (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: “New Safety Issue: Direct-Acting Antivirals Drugs…

Hepatitis C Drugs Viekira Pak And Technivie Require Warnings Label Changes Due To Liver Injury Reports

October 26, 2015

FDA Says The Timing Of Liver Injury Suggests That These Are Side Effects, Especially In Patients With Advanced Cirrhosis (Posted by Tom Lamb at DrugInjuryWatch.com) Viekira Pak and Technivie are relatively new…

Tag: hepatitis C drugs

Health Canada: There Is No Apparent Link Between Sovaldi Or Harvoni With Liver Cancer Recurrence As Of April 2017

February 2017 Label Changes For Sovaldi, Harvoni, And Other DAA Hepatitis C Drugs Are Made So As To Add A “Black-Box” Warning

New Safety Issue: Direct-Acting Antivirals Drugs For Hepatitis C Such As Harvoni And Sovaldi Could Cause Liver Failure

Is Liver Cancer Associated With Harvoni, Sovaldi, And Other Direct-Acting Antiviral Medications For Hepatitis C?

Hepatitis C Drugs Viekira Pak And Technivie Require Warnings Label Changes Due To Liver Injury Reports